![Estimation of Information Fraction with Fleming- Harrington type weighted log-rank test in clinical trials with interim look Madan G Kundu, PhD AbbVie. - ppt download Estimation of Information Fraction with Fleming- Harrington type weighted log-rank test in clinical trials with interim look Madan G Kundu, PhD AbbVie. - ppt download](https://slideplayer.com/17759113/105/images/slide_1.jpg)
Estimation of Information Fraction with Fleming- Harrington type weighted log-rank test in clinical trials with interim look Madan G Kundu, PhD AbbVie. - ppt download
STATISTICAL POWER OF AN ALTERNATIVE TEST FOR COMPARISON OF SURVIVAL DISTRIBUTIONS WITH CROSSED SURVIVAL CURVES IN THE PRESENCE O
![On information fraction for Fleming‐Harrington type weighted log‐rank tests in a group‐sequential clinical trial design - Kundu - 2021 - Statistics in Medicine - Wiley Online Library On information fraction for Fleming‐Harrington type weighted log‐rank tests in a group‐sequential clinical trial design - Kundu - 2021 - Statistics in Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a2b1ec88-f3e6-4bc7-91d6-08a413112bdc/sim8905-fig-0003-m.jpg)
On information fraction for Fleming‐Harrington type weighted log‐rank tests in a group‐sequential clinical trial design - Kundu - 2021 - Statistics in Medicine - Wiley Online Library
![Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-28410-9/MediaObjects/41467_2022_28410_Fig1_HTML.png)
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications
![A simulation study comparing the power of nine tests of the treatment effect in randomized controlled trials with a time-to-event outcome | Trials | Full Text A simulation study comparing the power of nine tests of the treatment effect in randomized controlled trials with a time-to-event outcome | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-020-4153-2/MediaObjects/13063_2020_4153_Fig1_HTML.png)
A simulation study comparing the power of nine tests of the treatment effect in randomized controlled trials with a time-to-event outcome | Trials | Full Text
![CIMAvax<sup>®</sup>EGF vaccine therapy for non-small cell lung cancer: A weighted log-rank tests-based evaluation CIMAvax<sup>®</sup>EGF vaccine therapy for non-small cell lung cancer: A weighted log-rank tests-based evaluation](https://www.scirp.org/html/paperimages/34723_1.jpg)